Dimitrakov D, Despotov T, Tsvetkova Z, Kumchev E, Kapon E, Pandeva S, Kuzmova M, Stavrev P, Sotirov A, Peshev Zh
Vutr Boles. 1990;29(5):109-13.
A case of a 20-year-old woman who developed a hemolytic-uremic syndrome while using the contraceptive drug Rigevidon is reported. Clinically the disease was manifested by acute renal failure, thrombocytopenic purpura and hemolytic anemia. The treatment with antiaggregants, anticoagulants, hemodialysis and plasmapheresis was without effect. The diagnosis was proved by the postmortem examination. The risks of the use of oral contraceptives and the need of new and better methods for contraception are discussed.